XML 21 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations (SARcode, Premacure and Lotus) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Lotus
Mar. 31, 2012
Lotus
Feb. 12, 2013
Lotus
Feb. 12, 2013
Lotus
purchase price allocation
Mar. 31, 2013
SARcode Biosciences Inc
Apr. 17, 2013
SARcode Biosciences Inc
Mar. 31, 2013
Premacure AB
Mar. 31, 2012
Premacure AB
Mar. 08, 2013
Premacure AB
Mar. 08, 2013
Premacure AB
purchase price allocation
Business Acquisition [Line Items]                        
Percentage of voting interests acquired         100.00%     100.00%     100.00%  
Cash consideration paid         $ 49.4     $ 150.0     $ 30.6  
Maximum amount of contingent cash consideration         275     525     169  
Integration and acquisition costs 4.10 5.30 1.00 0     0.20   0.30 0    
Acquisition-date fair value of consideration totaled         174.2           140.2  
Fair value of contingent consideration payable         124.8           109.6  
Net current assets assumed           6.8            
Goodwill     54.1     54.1           29.6
Net non-current liabilities assumed (including deferred tax liabilities)           63.4           29.5
IPR&D           176.7           151.8
Net current liabilities assumed                       $ 11.7